Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Bradley W. Christensen, Vlad G Zaha & Farrukh T. Awan. (2022) Cardiotoxicity of BTK inhibitors: ibrutinib and beyond. Expert Review of Hematology 15:4, pages 321-331.
Read now
Read now
Bronwyn C. Thorp & Xavier Badoux. (2018) Atrial fibrillation as a complication of ibrutinib therapy: clinical features and challenges of management. Leukemia & Lymphoma 59:2, pages 311-320.
Read now
Read now
Articles from other publishers (21)
Alexander R Lyon, Teresa López-Fernández, Liam S Couch, Riccardo Asteggiano, Marianne C Aznar, Jutta Bergler-Klein, Giuseppe Boriani, Daniela Cardinale, Raul Cordoba, Bernard Cosyns, David J Cutter, Evandro de Azambuja, Rudolf A de Boer, Susan F Dent, Dimitrios Farmakis, Sofie A Gevaert, Diana A Gorog, Joerg Herrmann, Daniel Lenihan, Javid Moslehi, Brenda Moura, Sonja S Salinger, Richard Stephens, Thomas M Suter, Sebastian Szmit, Juan Tamargo, Paaladinesh Thavendiranathan, Carlo G Tocchetti, Peter van der Meer, Helena J H van der Pal, Patrizio Lancellotti, Franck Thuny, Magdy Abdelhamid, Victor Aboyans, Berthe Aleman, Joachim Alexandre, Ana Barac, Michael A Borger, Ruben Casado-Arroyo, Jennifer Cautela, Jolanta Čelutkienė, Maja Cikes, Alain Cohen-Solal, Kreena Dhiman, Stéphane Ederhy, Thor Edvardsen, Laurent Fauchier, Michael Fradley, Julia Grapsa, Sigrun Halvorsen, Michael Heuser, Marc Humbert, Tiny Jaarsma, Thomas Kahan, Aleksandra Konradi, Konstantinos C Koskinas, Dipak Kotecha, Bonnie Ky, Ulf Landmesser, Basil S Lewis, Ales Linhart, Gregory Y H Lip, Maja-Lisa Løchen, Katarzyna Malaczynska-Rajpold, Marco Metra, Richard Mindham, Marie Moonen, Tomas G Neilan, Jens Cosedis Nielsen, Anna-Sonia Petronio, Eva Prescott, Amina Rakisheva, Joe-Elie Salem, Gianluigi Savarese, Marta Sitges, Jurrien ten Berg, Rhian M Touyz, Agnieszka Tycinska, Matthias Wilhelm, Jose Luis Zamorano, Nadia Laredj, Parounak Zelveian, Peter P Rainer, Fuad Samadov, Uladzimir Andrushchuk, Bernhard L Gerber, Mirsad Selimović, Elena Kinova, Jure Samardzic, Evagoras Economides, Radek Pudil, Kirsten M Nielsen, Tarek A Kafafy, Riina Vettus, Suvi Tuohinen, Stéphane Ederhy, Zurab Pagava, Tienush Rassaf, Alexandros Briasoulis, Dániel Czuriga, Karl K Andersen, Yvonne Smyth, Zaza Iakobishvili, Iris Parrini, Amina Rakisheva, Edita Pllana Pruthi, Erkin Mirrakhimov, Oskars Kalejs, Hadi Skouri, Hisham Benlamin, Diana Žaliaduonytė, Alessandra Iovino, Alice M Moore, Daniela Bursacovschi, Aatif Benyass, Olivier Manintveld, Marijan Bosevski, Geeta Gulati, Przemysław Leszek, Manuela Fiuza, Ruxandra Jurcut, Yury Vasyuk, Marina Foscoli, Dragan Simic, Miroslav Slanina, Luka Lipar, Ana Martin-Garcia, Laila Hübbert, Reto Kurmann, Ahmad Alayed, Leila Abid, Cafer Zorkun, Elena Nesukay, Charlotte Manisty, Nigora Srojidinova, Colin Baigent, Magdy Abdelhamid, Victor Aboyans, Sotiris Antoniou, Elena Arbelo, Riccardo Asteggiano, Andreas Baumbach, Michael A Borger, Jelena Čelutkienė, Maja Cikes, Jean-Philippe Collet, Volkmar Falk, Laurent Fauchier, Chris P Gale, Sigrun Halvorsen, Bernard Iung, Tiny Jaarsma, Aleksandra Konradi, Konstantinos C Koskinas, Dipak Kotecha, Ulf Landmesser, Basil S Lewis, Ales Linhart, Maja-Lisa Løchen, Richard Mindham, Jens Cosedis Nielsen, Steffen E Petersen, Eva Prescott, Amina Rakisheva, Marta Sitges & Rhian M Touyz. (2022) 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). European Heart Journal 43:41, pages 4229-4361.
Crossref
Crossref
Alexander R Lyon, Teresa López-Fernández, Liam S Couch, Riccardo Asteggiano, Marianne C Aznar, Jutta Bergler-Klein, Giuseppe Boriani, Daniela Cardinale, Raul Cordoba, Bernard Cosyns, David J Cutter, Evandro de Azambuja, Rudolf A de Boer, Susan F Dent, Dimitrios Farmakis, Sofie A Gevaert, Diana A Gorog, Joerg Herrmann, Daniel Lenihan, Javid Moslehi, Brenda Moura, Sonja S Salinger, Richard Stephens, Thomas M Suter, Sebastian Szmit, Juan Tamargo, Paaladinesh Thavendiranathan, Carlo G Tocchetti, Peter van der Meer, Helena J H van der Pal, Patrizio Lancellotti, Franck Thuny, Magdy Abdelhamid, Victor Aboyans, Berthe Aleman, Joachim Alexandre, Ana Barac, Michael A Borger, Ruben Casado-Arroyo, Jennifer Cautela, Jolanta Čelutkienė, Maja Cikes, Alain Cohen-Solal, Kreena Dhiman, Stéphane Ederhy, Thor Edvardsen, Laurent Fauchier, Michael Fradley, Julia Grapsa, Sigrun Halvorsen, Michael Heuser, Marc Humbert, Tiny Jaarsma, Thomas Kahan, Aleksandra Konradi, Konstantinos C Koskinas, Dipak Kotecha, Bonnie Ky, Ulf Landmesser, Basil S Lewis, Ales Linhart, Gregory Y H Lip, Maja Lisa Løchen, Katarzyna Malaczynska-Rajpold, Marco Metra, Richard Mindham, Marie Moonen, Tomas G Neilan, Jens Cosedis Nielsen, Anna Sonia Petronio, Eva Prescott, Amina Rakisheva, Joe Elie Salem, Gianluigi Savarese, Marta Sitges, Jurrien ten Berg, Rhian M Touyz, Agnieszka Tycinska, Matthias Wilhelm, Jose Luis Zamorano, Nadia Laredj, Parounak Zelveian, Peter P Rainer, Fuad Samadov, Uladzimir Andrushchuk, Bernhard L Gerber, Mirsad Selimović, Elena Kinova, Jure Samardzic, Evagoras Economides, Radek Pudil, Kirsten M Nielsen, Tarek A Kafafy, Riina Vettus, Suvi Tuohinen, Stéphane Ederhy, Zurab Pagava, Tienush Rassaf, Alexandros Briasoulis, Dániel Czuriga, Karl K Andersen, Yvonne Smyth, Zaza Iakobishvili, Iris Parrini, Amina Rakisheva, Edita Pllana Pruthi, Erkin Mirrakhimov, Oskars Kalejs, Hadi Skouri, Hisham Benlamin, Diana Žaliaduonytė, Alessandra Iovino, Alice M Moore, Daniela Bursacovschi, Aatif Benyass, Olivier Manintveld, Marijan Bosevski, Geeta Gulati, Przemysław Leszek, Manuela Fiuza, Ruxandra Jurcut, Yury Vasyuk, Marina Foscoli, Dragan Simic, Miroslav Slanina, Luka Lipar, Ana Martin-Garcia, Laila Hübbert, Reto Kurmann, Ahmad Alayed, Leila Abid, Cafer Zorkun, Elena Nesukay, Charlotte Manisty & Nigora Srojidinova. (2022) 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). European Heart Journal - Cardiovascular Imaging 23:10, pages e333-e465.
Crossref
Crossref
Marion Allouchery, Cécile Tomowiak, Stéphanie Guidez, Vincent Delwail, Paul Delaunay, Claire Lafay‐Chebassier, Francesco Salvo & Marie‐Christine Pérault‐Pochat. (2020) Patterns of use and safety of ibrutinib in real‐life practice. British Journal of Clinical Pharmacology 87:3, pages 895-904.
Crossref
Crossref
Atooshe RohaniAtooshe Rohani. 2021. Clinical Cases in Cardio-Oncology. Clinical Cases in Cardio-Oncology
71
74
.
Ling XiaoJoe-Elie Salem, Sebastian Clauss, Alan HanleyAneesh BapatMaarten Hulsmans, Yoshiko IwamotoGregory Wojtkiewicz, Murat CetinbasMaximilian J. SchlossJustin TedeschiBénédicte Lebrun-VignesAlicia LundbyRuslan I. SadreyevJavid MoslehiMatthias Nahrendorf, Patrick T. Ellinor & David J Milan. (2020) Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase. Circulation 142:25, pages 2443-2455.
Crossref
Crossref
Hun J. Lee, Jacob L. Schmelz, Fred Cramer, Jorge E. Romaguera, Maria Badillo & Michael Wang. (2020) A phase I study of carfilzomib in combination with ibrutinib for relapsed refractory mantle cell lymphoma. British Journal of Haematology 188:6.
Crossref
Crossref
Abdulrazzak Zarifa, Aya Albittar, Peter Y. Kim, Saamir Hassan, Nicolas Palaskas, Cezar Iliescu, Jean-Bernard Durand & Juan Lopez-Mattei. (2019) Cardiac toxicities of anticancer treatments. Current Opinion in Cardiology 34:4, pages 441-450.
Crossref
Crossref
Sanam Shafaattalab, Eric Lin, Effimia Christidi, Haojun Huang, Yulia Nartiss, Analucia Garcia, Jeehon Lee, Stephanie Protze, Gordon Keller, Liam Brunham, Glen F. Tibbits & Zachary Laksman. (2019) Ibrutinib Displays Atrial-Specific Toxicity in Human Stem Cell-Derived Cardiomyocytes. Stem Cell Reports 12:5, pages 996-1006.
Crossref
Crossref
E.I. Emelina, Gennadii Efimovich Gendlin, I.G. Nikitin, E.A. Dmitrieva, E.A. Nikitin & V.V. Ptushkin. (2019) Rhythm and Conduction Disorders in Patients Receiving Ibrutinib. Clinical oncohematology 12:2, pages 120-130.
Crossref
Crossref
Juan Lopez-Mattei, Peter Kim & Cezar Iliescu. (2019) Editorial Commentary: Update on cardio-oncology: Novel cancer therapeutics and associated cardiotoxicities. Trends in Cardiovascular Medicine 29:1, pages 40.
Crossref
Crossref
Richard Caldwell, Lesley Liu-Bujalski, Hui Qiu, Igor Mochalkin, Reinaldo Jones, Constantin Neagu, Andreas Goutopoulos, Roland Grenningloh, Theresa Johnson, Brian Sherer, Anna Gardberg, Ariele Viacava Follis, Federica Morandi & Jared Head. (2018) Discovery of a novel series of pyridine and pyrimidine carboxamides as potent and selective covalent inhibitors of Btk. Bioorganic & Medicinal Chemistry Letters 28:21, pages 3419-3424.
Crossref
Crossref
Daniel F. Pease & Vicki A. Morrison. (2018) Treatment of mantle cell lymphoma in older adults. Journal of Geriatric Oncology 9:4, pages 308-314.
Crossref
Crossref
C. Skrabs, W. F. Pickl, T. Perkmann, U. Jäger & A. Gessl. (2018) Rapid decline in insulin antibodies and glutamic acid decarboxylase autoantibodies with ibrutinib therapy of chronic lymphocytic leukaemia. Journal of Clinical Pharmacy and Therapeutics 43:1, pages 145-149.
Crossref
Crossref
D. Haddad, A. Guha, F. Awan, E.G. Daoud & R. Baliga. 2018. Encyclopedia of Cardiovascular Research and Medicine. Encyclopedia of Cardiovascular Research and Medicine
162
181
.
A. Guha. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Hui-Ming Chang, Tochukwu M. Okwuosa, Tiziano Scarabelli, Rohit Moudgil & Edward T.H. Yeh. (2017) Cardiovascular Complications of Cancer Therapy. Journal of the American College of Cardiology 70:20, pages 2552-2565.
Crossref
Crossref
Tracy E. Wiczer, Lauren B. Levine, Jessica Brumbaugh, Jessica Coggins, Qiuhong ZhaoAmy S. RuppertKerry RogersAnli McCoy, Luay MousaAvirup Guha, Nyla A. Heerema, Kami MaddocksBeth ChristianLeslie A. AndritsosSamantha JaglowskiSteven DevineRobert BaiocchiJennifer WoyachJeffrey JonesMichael GreverKristie A. BlumJohn C. ByrdFarrukh T. Awan. (2017) Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib. Blood Advances 1:20, pages 1739-1748.
Crossref
Crossref
Manuela Hoechstetter. (2017) Chronische lymphatische LeukämieChronic lymphocytic leukemia. e.Curriculum Innere Medizin.
Crossref
Crossref
Naveed Ali, Faizan Malik, Syed Imran Mustafa Jafri, Mary Naglak, Mark Sundermeyer & Peter V. Pickens. (2017) Analysis of Efficacy and Tolerability of Bruton Tyrosine Kinase Inhibitor Ibrutinib in Various B-cell Malignancies in the General Community: A Single-center Experience. Clinical Lymphoma Myeloma and Leukemia 17, pages S53-S61.
Crossref
Crossref
Kanupriya Mathur, Aditya Saini, Kenneth A. Ellenbogen & Richard K. Shepard. (2017) Profound Sinoatrial Arrest Associated with Ibrutinib. Case Reports in Oncological Medicine 2017, pages 1-3.
Crossref
Crossref
. (2016) Ibrutinib. Reactions Weekly 1629:1, pages 133-133.
Crossref
Crossref